In News

Follow this topic

Bookmark

Record learning outcomes

The National Pharmacy Association chief executive Henry Gregg has said manufacturers whose mistakes lead to medicines recalls should reimburse affected pharmacies.

Reacting to Amarox Limited’s recall yesterday of a batch of Sertraline 100mg film-coated tablets after a manufacturing error, Gregg (pictured) said pharmacies suffer time-consuming knock-on effects of recalls, including having to quarantine stock and contact patients. 

In the case of the batch of Sertraline 100mg, two antidepressant medicines were incorrectly packaged.

“This has potentially serious consequences for patients and is deeply frustrating for pharmacies,” Gregg said.

“Hard-pressed pharmacy teams spend hours of their time contacting patients who have received these prescriptions as well as quarantining stock, time they could be spending delivering patient care instead.

“Pharmacies who bear the brunt of any recall should be reimbursed for the cost of these mistakes by the manufacturers who make them.”

Independent Community Pharmacist has contacted Amarox Limited for a response.

Tell us about the impact medicines recalls are having on your pharmacy by emailing neil.trainis@1530.com